Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Filings indexed 3,174 across all filing types
Latest filing 2024-10-21 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Issue of Duplicate Share Certificate
Regulatory Filings Classification · 100% confidence The document is a compliance certificate submitted under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the issuance of duplicate share certificates in lieu of lost certificates. The content is a formal regulatory compliance communication to the stock exchange, not a financial report, earnings release, or management discussion. It does not contain financial statements or analysis, nor does it announce voting results or capital changes. It is a regulatory filing related to share certificate compliance. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short and it is a certificate, not a report itself, so it is not a report publication announcement (RPA).
2024-10-21 English
Issue of Duplicate Share Certificate
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the issuance of duplicate share certificates in lieu of lost certificates. The document is addressed to the National Stock Exchange of India and signed by the company secretary. It does not contain financial statements, earnings data, or management discussion. It is a regulatory compliance filing related to share certificates, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-10-21 English
Intimation regarding issuance of duplicate share certificates.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the issuance of duplicate share certificates in lieu of lost certificates. The document is a formal regulatory compliance submission to the stock exchange (BSE Limited) and does not contain financial statements, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital update. The document is a regulatory filing related to share certificate compliance, which fits best under the category of Regulatory Filings (RNS). The document length is short and focused on compliance certification, not a report or announcement of a report publication.
2024-10-21 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding the appointment of a senior management personnel, Mr. Claus Jepsen, by the company's wholly owned subsidiary. It references compliance with SEBI Listing Regulations and provides details about the appointment and the appointee's profile. The content focuses solely on management change without financial data or report content. The document length is under 5,000 characters and is clearly an announcement of a management change rather than a full management report or annual report. Therefore, it fits the category of Board/Management Information (MANG).
2024-10-18 English
Appointment of Senior Management Personnel by its wholly owned subsidiary.
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges regarding the appointment of a senior management personnel, Mr. Claus Jepsen, by the company's wholly owned subsidiary. It references compliance with SEBI Listing Regulations and provides details about the appointment and the appointee's profile. There are no financial statements, earnings data, or report attachments. The content clearly fits the category of announcing changes in senior management rather than a full management report or other filings.
2024-10-18 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details received from a shareholder. It is a formal regulatory communication to stock exchanges, signed by the company secretary. The document does not contain financial statements, management discussion, or report data. It is a regulatory filing related to compliance and shareholder information, not a financial report or announcement of a meeting or dividend. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and focused on compliance, confirming this classification.
2024-10-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.